Challenges and strategies in management of osteoporosis and fragility fracture care during COVID-19 pandemic

Gaurav K Upadhyaya, Karthikeyan Iyengar, Vijay K Jain, Raju Vaishya, Gaurav K Upadhyaya, Karthikeyan Iyengar, Vijay K Jain, Raju Vaishya

Abstract

Background: COVID-19 has resulted in restriction of face to face consultations and mechanisms to access health care. Osteoporosis and fragility fractures forms a significant proportion of adult trauma and orthopaedic workload even during the pandemic.

Aims: We assess the challenges and strategies used in the management of osteoporosis and fragility fracture care during the COVID-19 pandemic.

Methods: We have done a comprehensive review of the literature using suitable keywords on the search engines of PubMed, SCOPUS, Google Scholar and Research Gate in the first week of May 2020 on developments and guidance during the current COVID-19 pandemic.

Results: Osteoporosis and fragility fractures management has been hampered by lock down and infection transmission strategies used to contain the COVID-19 pandemic. Access to diagnostic tests, treatment facilities with the need to use clinical and prediction tools to guide management Telemedicine has an evolving role.

Conclusion: Osteoporosis and fragility fractures in elderly individuals pose a real challenge for an appropriate diagnosis and management, during the COVID-19 pandemic. A clinical decision along with use of clinical prediction tools for osteoporosis should be used to direct treatment. Obligatory fractures such as hip fractures require operative intervention. Non-obligatory fractures such as distal radius fractures can be managed conservatively with use of telemedicine applications in monitoring both types of patients.

Keywords: COVID-19; Coronavirus; Fracture; Osteoporosis; Pandemics; Spontaneous.

© 2020 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.

References

    1. Nicola M., Alsafi Z., Sohrabi C. The socio-economic implications of the coronavirus and COVID-19 pandemic: a review [published online ahead of print, 2020 apr 16] Int J Surg. 2020;S1743–9191 doi: 10.1016/j.ijsu.2020.04.018. 20)30316-2.
    1. Stahel P.F. How to risk-stratify elective surgery during the COVID-19 pandemic? Patient Saf Surg. 2020;14:8. doi: 10.1186/s13037-020-00235-9. Published 2020 Mar 31.
    1. NHS England and NHS Improvement Coronavirus . 2020. Specialty Guides-Major Trauma.
    1. Sahagun L. 01 April 2020. Coronavirus Stay-At-Home Orders that Went into Effect on March 20 Have Reduced Vehicle Collisions on California Roadways by Roughly Half.
    1. Cauley J.A. Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci. 2013;68(10):1243‐1251. doi: 10.1093/gerona/glt093.
    1. Riemen A.H., Hutchison J.D. The multidisciplinary management of hip fractures in older patients. Orthop Trauma. 2016;30(2):117–122. doi: 10.1016/j.mporth.2016.03.006.
    1. Sözen T., Özışık L., Başaran N.Ç. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46‐56. doi: 10.5152/eurjrheum.2016.048.
    1. Kaushal N.(1. Vohora D(1), Jalali RK(2), Jha S(3). Prevalence of osteoporosis and osteopenia in an apparently healthy Indian population - a cross-sectional retrospective study. Osteoporosis Sarcopenia. 2018 Jun;4(2):53–60. doi: 10.1016/j.afos.2018.04.002. Epub 2018 May 5.
    1. Mehta N., Garg B., Malhotra R. Management of fragility fractures in India [published correction appears in best pract res clin rheumatol. 2020 feb 24; 101488] Best Pract Res Clin Rheumatol. 2019;33(2):301‐309. doi: 10.1016/j.berh.2019.05.002.
    1. Borgström F., Karlsson L., Ortsäter G. Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. 2020;15(1):59. doi: 10.1007/s11657-020-0706-y. . Published 2020 Apr 19.
    1. Mithal A., Bansal B., Kyer C.S., EbelingThe P. Asia-Pacific regional audit-epidemiology, costs, and burden of osteoporosis in India 2013: a report of International Osteoporosis Foundation. Indian J Endocrinol Metab. 2014;18:449–454.
    1. Malhotra N., Mithal A. Osteoporosis in Indians. Indian J Med Res. 2008;127(3):263–268.
    1. Haleem A., Javaid M., Vaishya R. Effects of COVID 19 pandemic in daily life [published online ahead of print, 2020 Apr 3] Curr Med Res Pract. 2020 doi: 10.1016/j.cmrp.2020.03.011. doi:10.1016/j.cmrp.2020.03.011.
    1. Grant W.B., Lahore H., McDonnell S.L. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):E988. doi: 10.3390/nu12040988. Published 2020 Apr 2.
    1. Kanis J.A., Oden A., Johnell O., Jonsson B., de Laet C., Dawson A. Osteoporos Int. 2001;12(5):417–427. The burden of osteoporotic fractures: a method for setting intervention thresholds.
    1. National Institute for Health and Clinical Excellence . NICE; London: 2012. Osteoporosis: Assessing the Risk of Fragility Fracture. NICE Clinical Guideline 146. accessed on 12 May 2020.
    1. Shariyate M., Kachooei A. Association of new coronavirus disease with fragility hip and lower limb fractures in elderly patients. The Archives of Bone and Joint Surgery. 2020;8(Covid-19 Special Issue):297–301. doi: 10.22038/abjs.2020.47626.2333.
    1. British Geriatrics Society . 2020. Managing Hip Fractures during COVID-19. accessed on 12 May 2020.
    1. NHS England. 2020. accessed on 12 May 2020.
    1. The Lancet. India under COVID-19 lockdown. Lancet. 2020;395(10233):1315. doi: 10.1016/S0140-6736(20)30938-7.
    1. Cimino Steve. May 12,2020. Don't Neglect Osteoporosis Therapy during COVID-19. Say Societies.
    1. Nuti R., Brandi M.L., Checchia G. Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med. 2019 Jan;14(1):85–102. doi: 10.1007/s11739-018-1874-2.
    1. World Health Organization Centre for Metabolic Bone Diseases FRAX®. accessed 12 may 2020.
    1. Skedros J.G.(1), Sybrowsky C.L., Stoddard G.J. The osteoporosis self-assessment screening tool: a useful tool for the orthopaedic surgeon. J Bone Joint Surg Am. 2007;89(4):765–772.
    1. Pongchaiyakul C., Wanothayaroj E. Performance of the Khon kaen osteoporosis study (KKOS) score for identifying osteoporosis in men. J Med Assoc Thai. 2007 Aug;90(8):1518–1523.
    1. Pazianas M., Cooper C., Ebetino F.H., Russell R.G. Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis. Therapeut Clin Risk Manag. 2010 Jul;6:325–343. doi: 10.2147/tcrm.s8054.
    1. Popp A.W., Senn R., Curkovic I. Factors associated with acute-phase response of bisphosphonate-naive or pre-treated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate. Osteoporos Int. 2017;28(6):1995–2002.
    1. Crotti C., Watts N.B., De Santis M. Acute phase reactions after zoledronic acid infusion: protective role of 25-hydroxyvitamin D and previous Oral bisphosphonate therapy. Endocr Pract. 2018;24(5):405–410.
    1. Diker-Cohen T., Rosenberg D., Avni T., Shepshelovich D., Tsvetov G., Gafter-Gvili A. Risk for infections during treatment with denosumab for osteoporosis: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2020 May 1;(5):105. doi: 10.1210/clinem/dgz322. pii: dgz322.
    1. Miller P.D., Wagman R.B., Peacock M. Effect of Denosumab on bone mineral density and biochemical markers of bone turnover: six-year results of a phase 2 clinical trial. J Clin Endocrinol Metab. 2011;96(2):394–402.
    1. Bone H.G., Bolognese M.A., Yuen C.K. Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J Clin Endocrinol Metab. 2011;96(4):972–980.
    1. Cummings S.R., Ferrari S., Eastell R. Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM Trial and its extension. J Bone Miner Res. 2018;33(2):190–198.
    1. Greenhalgh T., Wherton J., Shaw S., Morrison C. Video consultations for covid-19. BMJ. 2020;368:m998. doi: 10.1136/bmj.m998. Published 2020 Mar 12.
    1. Joint Guidance on Osteoporosis Management in the Era of COVID-19 from the American Society for Bone and Mineral Research (ASBMR), American Association of Clinical Endocrinologists (AACE), Endocrine Society, European Calcified Tissue Society (ECTS) and National Osteoporosis Foundation (NOF).
    1. Terpos E., Ntanasis-Stathopoulos I., Elalamy I. Haematological findings and complications of COVID-19. Am J Hematol. 2020 Apr 13 doi: 10.1002/ajh.25829. [Epub ahead of print]
    1. Spiezia L., Boscolo A., Poletto F., Cerruti L., Tiberio I., Campello E. COVID-19 related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemostasis. 2020 Apr 21 doi: 10.1055/s-0040-1710018. [Epub ahead of print]
    1. Jain V.K., Vaishya R. COVID-19 and orthopaedic surgeons: the Indian scenario. Trop Doct. 2020;50(2):108–110. doi: 10.1177/0049475520921616.
    1. Muñoz Vives JM, Jornet-Gibert M, Cámara-Cabrera J, et al. Mortality rates of patients with proximal femoral fracture in a worldwide pandemic: preliminary results of the Spanish HIP-COVID observational study. J Bone Joint Surg Am. 2020 May 6, 127(3). doi: 10.2106/JBJS.20.00686. Online ahead of print.
    1. Catellani F., Coscione A., D'Ambrosi R., Usai L., Roscitano C., Fiorentino G. Treatment of proximal femoral fragility fractures in patients with COVID-19 during the SARS-CoV-2 outbreak in northern Italy [published online ahead of print, 2020 apr 28] J Bone Joint Surg Am. 2020 doi: 10.2106/JBJS.20.00617. doi:10.2106/JBJS.20.00617.
    1. NHS England and NHS Improvement Coronavirus . 2020. Specialty Guides-Major Trauma.
    1. British Orthopaedic Association . 2020. Speciality Guidelines. accessed 12May 2020.
    1. Kannus P., Parkkari J. Prevention of hip fracture with hip protectors. Age Ageing. 2006 Sep;35 Suppl 2:ii51-ii54. Review.
    1. Vaishya R · Vaish A. Falls in older adults are serious. Indian J Orthop. 2020;54:69–74.
    1. Faster Protection with Less Material. Accessed 12 May 2020.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe